Eyegate Pharmaceuticals Inc.

(EYEG) Trade

By |

Profile

Eyegate Pharmaceuticals Inc is a US-based clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The company's lead product EGP-437 incorporates a reformulated topically active corticosteroid, Dexamethasone Phosphate, that is delivered into the ocular tissues through proprietary drug delivery system, the EyeGate II Delivery System. It mainly develops EGP-437 for the treatment of various inflammatory conditions of the eye, including the treatment of ocular inflammation and pain in post-surgical cataract patients and uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and ciliary body.

Contact Information

Website: www.eyegatepharma.com
Main Phone: +1 781 788-9043
Address: 271 Waverley Oaks Road
Address 2: Suite 108
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02452

Issuer Information

Exchange: NSC
CEO: Stephen From
Employees: 17
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 0.53 $ -0.0021 (-0.40%)
Last Price 0.53 Change $ -0.0021 Change % -0.40 Tick N/A
Bid 0.50 Bid Size 300.00 Ask 0.53 Ask Size 200.00
Open 0.54 High 0.54 Low 0.50 Prev Close 0.53
Last Trade Volume 45,921 52 Wk Hi 1.34 52 Wk Low 0.28
Market Cap 22.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 43,443,878.00 EPS (TTM) -0.43 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 18
Number of Buys 8 18
Number of Sells 0 0
Net Activity 371780 471775
Last 10 Buys Shares
Michael Garanzini 1,000
Stephen From 1,000
Sarah M. Romano 1,000
Sarah M. Romano 1,000
Stephen From 1,000
Sarah M. Romano 1,000
Stephen From 1,000
Stephen From 1,000
Paul G. Chaney 1,000
Last 10 Sell Shares
Morton F. Goldberg 1,000
Morton F. Goldberg 1,000
Morton F. Goldberg 1,000
Morton F. Goldberg 1,000
Morton F. Goldberg 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3.33 3.33 3.33 3.33
Standard Deviation 0.58 0.58 0.58 0.58
Date of Most Recent Estimate 05/31/18 05/31/18 04/10/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1